Trial Profile
Phase II trial of tesetaxel monotherapy as second-line therapy in patients with advanced gastric cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2010
Price :
$35
*
At a glance
- Drugs Tesetaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Genta
- 01 Apr 2010 New trial record
- 20 Jun 2006 Results were presented at the 2006 ASCO Annual Meeting.